...门静脉化疗 [gap=1153]in tumor thrombus;Transcatheter Arterial Chemoembolization;Drug Delivery System;portal vein chemotherapy ...
基于26个网页-相关网页
门静脉化疗栓塞 SPVE
及门静脉化疗 portal vein chemotherapy
和门静脉化疗 portal vein chemotherapy
肝动脉门静脉化疗 HAPVC
分别采用门静脉化疗 portal vein chemotherapy
选择性门静脉化疗栓塞 selective portal vein chemoembolization
门静脉栓塞化疗 PVCE ; SPVE ; portal vein chemoembolization ; portal vein chemo
门静脉灌注化疗 IPIC ; portal vein chemotherapy
肝门静脉栓塞化疗 portal vein chemoembolization ; PVCE
目的探讨超声引导下局部治疗结合门静脉化疗在中晚期肝癌中的应用。
Objective To investigate the application of local treatment combining with chemotherapy via portal vein guided by US in advanced hepatic cancer.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
应用推荐